| scholarly article | Q13442814 |
| P50 | author | Bruno Sangro | Q56418908 |
| Jesús Prieto | Q28324697 | ||
| P2093 | author name string | Beloqui O | |
| Civeira MP | |||
| Yuste JR | |||
| Aguirre B | |||
| Riezu JI | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| hepatitis C | Q154869 | ||
| chronic hepatitis C | Q55779873 | ||
| chronic hepatitis | Q62019625 | ||
| Hepatitis C virus | Q708693 | ||
| P1104 | number of pages | 6 | |
| P304 | page(s) | 199-204 | |
| P577 | publication date | 1996-02-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome | |
| P478 | volume | 23 |
| Q45418780 | Anti-PCNA autoantibodies preferentially recognize C-terminal of PCNA in patients with chronic hepatitis B virus infection |
| Q81512797 | Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus |
| Q73314704 | Anticardiolipin antibodies in hemodialysis patients |
| Q33331690 | Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: characterization in relation to antiphospholipid syndrome |
| Q35107007 | Antiphospholipid antibodies and infections |
| Q28364192 | Antiphospholipid antibodies associated with alcoholic liver disease specifically recognise oxidised phospholipids |
| Q43882937 | Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo |
| Q33382848 | Antiphospholipid antibodies: paradigm in transition |
| Q37045158 | Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview |
| Q35553410 | Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients |
| Q36524424 | Antiviral treatment down-regulates peripheral B-cell CD81 expression and CD5 expansion in chronic hepatitis C virus infection |
| Q28082873 | Associations of antiphospholipid antibodies with splanchnic vein thrombosis: a systematic review with meta-analysis |
| Q33698258 | Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis. |
| Q33379576 | Cell damage at the origin of antiphospholipid antibodies and their pathogenic potential in recurrent pregnancy loss |
| Q33378075 | Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients |
| Q87355706 | Clinical relevance of antibodies to cardiolipin in patients with chronic hepatitis C |
| Q28362586 | Cofactor dependence and isotype distribution of anticardiolipin antibodies in viral infections |
| Q50585639 | Development of lupic anticoagulant during combination therapy in a patient with chronic hepatitis C. |
| Q64084136 | Effectiveness of venous thromboembolism prophylaxis in patients with liver disease |
| Q42997230 | Expansion of peripheral blood CD5+ B cells is associated with mild disease in chronic hepatitis C virus infection. |
| Q36255956 | Hepatitis C Virus Infection Associated With an Increased Risk of Deep Vein Thrombosis: A Population-Based Cohort Study |
| Q38497354 | Hepatitis C virus and autoimmunity |
| Q41377154 | Hepatitis C virus infection and autoimmunity |
| Q41669589 | Hepatitis C virus, autoimmunity and rheumatic disease |
| Q74600350 | Hepatitis C-associated autoimmune disorders |
| Q90388064 | Hypercoagulability in End-stage Liver Disease: Review of Epidemiology, Etiology, and Management |
| Q92531766 | Hyponatremia Is Protective Against the Development of Portal Vein Thrombosis in Patients Undergoing Liver Transplant |
| Q27477934 | Idiopathic dilated cardiomyopathy: lack of association with hepatitis C virus infection |
| Q27015533 | Immune Components of Liver Damage Associated with Connective Tissue Diseases |
| Q73401703 | Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis |
| Q45077755 | Intrauterine fetal death in mice caused by cytomegalovirus-derived peptide induced aPL antibodies |
| Q58854434 | Lymphomes malins et syndrome des antiphospholipides non simultanés : quatre observations |
| Q33498803 | Mechanisms of thrombocytopenia induced by interferon therapy for chronic hepatitis B. |
| Q40836416 | Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients |
| Q97886328 | No Association between Ischemic Stroke and Portal Vein Thrombosis in Liver Cirrhosis |
| Q26770595 | Occult HCV Infection: The Current State of Knowledge |
| Q77796443 | Opposite beta2-glycoprotein I requirement for the binding of infectious and autoimmune antiphospholipid antibodies to cardiolipin liposomes is associated with antibody avidity |
| Q34354708 | Origin of antiphospholipid antibodies. |
| Q27480668 | Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection |
| Q44310007 | Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin |
| Q35548278 | Presentation of autoantibody to proliferating cell nuclear antigen in patients with chronic hepatitis B and C virus infection |
| Q44988512 | Prevalence of antiphospholipid antibodies in patients with chronic liver disease related to alcohol or hepatitis C virus: correlation with liver injury. |
| Q42993885 | Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome |
| Q38038832 | Review: Viral infections and mechanisms of thrombosis and bleeding |
| Q26773278 | Rheumatic manifestations of hepatitis C virus chronic infection: Indications for a correct diagnosis |
| Q77803126 | Rheumatologic manifestations of gastrointestinal diseases |
| Q41930841 | Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis. |
| Q36167378 | Rituximab-based treatment, HCV replication, and hepatic flares |
| Q33839099 | Serum Biomarkers for Discrimination between Hepatitis C-Related Arthropathy and Early Rheumatoid Arthritis |
| Q73738644 | Specificity of anti-phospholipid antibodies in infectious mononucleosis: a role for anti-cofactor protein antibodies |
| Q34317744 | The antiphospholipid syndrome and infection |
| Q26749460 | Thrombin activation and liver inflammation in advanced hepatitis C virus infection |
| Q33440130 | Thrombocytopenia in Patients with Chronic Hepatitis C Virus Infection |
| Q26781784 | Thrombosis Associated with Viral Hepatitis |
| Q33443797 | Thrombosis and antiphospholipid antibody syndrome during acute Q fever: A cross-sectional study |
| Q35595386 | Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis |
| Q33340288 | Treatment of hepatitis C related thrombocytopenia with interferon alpha |
| Q33348373 | Unusual manifestations of the antiphospholipid syndrome |
| Q73361339 | [Distal gangrene and cryoglobulinemia related to hepatitis C virus infection with presence of anticardiolipin antibodies] |
| Q74043108 | [Prevalence and clinical significance of hepatitis C virus infection in systemic autoimmune diseases] |
| Q79331109 | [Reccurent stroke revealing catastrophic antiphospholipid syndrome with hepatitis C viral infection] |
| Q73230125 | [The etiopathogenic role of hepatitis virus C in the antiphospholipid syndrome] |
Search more.